Blog

When starting a GLP-1 weight-management medicine, the first weeks often focus on tolerability and routine rather than maximum effect. Approved semaglutide injection schedules begin at

Semaglutide has an elimination half-life of about one week. Current Wegovy prescribing information states that semaglutide may remain in circulation for roughly five to seven

Yes, semaglutide can reduce appetite for some people. Current prescribing information states that semaglutide decreases calorie intake and that its body-weight effects are likely mediated

Semaglutide begins acting after it is taken, but noticeable weight-management results usually develop over time. Some people notice appetite or fullness changes before a large

A healthy eating plan with semaglutide emphasizes nutrient-dense foods rather than extreme restriction. Prioritize adequate protein, vegetables and fruit, high-fiber carbohydrates as tolerated, healthy fats

There is no single FDA list of foods that everyone must avoid with semaglutide. However, very large meals, high-fat or fried foods, heavy alcohol intake

Exercise remains important during semaglutide treatment because weight management is about health, fitness and function, not only scale change. Aerobic activity supports cardiovascular fitness, while

Protein remains important during semaglutide-assisted weight loss because the body can lose lean tissue as well as fat. Lower appetite may make adequate intake harder.

Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GIP and GLP-1 receptors. Both have FDA-approved products for chronic weight management, but they differ

Semaglutide and liraglutide are both GLP-1 receptor agonists, but they are different molecules with different dosing schedules and product labeling. Wegovy semaglutide injection is generally